Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2016 11:00 ET | Source: Relypsa, Inc.

Data from New Analyses of Studies with Veltassa® Presented at 53rd European Renal Association Congress

REDWOOD CITY, Calif., May 22, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that data from new analyses of studies with Veltassa® (patiromer) for...
May 18, 2016 16:05 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., May 18, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on May 16, 2016, the compensation committee of the company’s...
May 05, 2016 16:15 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on May 2, 2016, the compensation committee of the company’s...
May 04, 2016 16:05 ET | Source: Relypsa, Inc.

Relypsa Reports First Quarter 2016 Financial Results

Relypsa Management to Host Conference Call/Webcast this Afternoon at 5:00 p.m. ET/2:00 p.m. PT REDWOOD CITY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a...
May 03, 2016 16:15 ET | Source: Relypsa, Inc.

Relypsa Announces $150 Million Debt Financing

REDWOOD CITY, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced the closing of $150 million in aggregate principal amount of senior...
May 02, 2016 16:15 ET | Source: Relypsa, Inc.

Relypsa to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that John A. Orwin, president and chief executive officer, will present at the Bank of America...
April 28, 2016 18:00 ET | Source: Relypsa, Inc.

Data from New Analyses of Studies with Veltassa® Presented at National Kidney Foundation 2016 Spring Clinical Meetings

REDWOOD CITY, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced data from new analyses of studies with Veltassa® (patiromer) for...
April 27, 2016 16:15 ET | Source: Relypsa, Inc.

Relypsa to Report First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 4, 2016

REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that the company will report first quarter 2016 financial results...
April 25, 2016 08:30 ET | Source: Relypsa, Inc.

Vifor Fresenius Medical Care Renal Pharma and Relypsa Announce Submission of Marketing Authorization Application Requesting European Approval of Veltassa® for the Treatment of Hyperkalemia

ST. GALLEN, Switzerland and REDWOOD CITY, Calif., April 25, 2016 (GLOBE NEWSWIRE) -- Vifor Fresenius Medical Care Renal Pharma Ltd. (VFMCRP), a common company of Galenica and Fresenius Medical...
April 21, 2016 16:15 ET | Source: Relypsa, Inc.

Relypsa Announces Upcoming Veltassa® Data Presentations at National Kidney Foundation 2016 Spring Clinical Meetings

REDWOOD CITY, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that new analyses from studies of Veltassa® (patiromer) for oral...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right